JP2018537408A5 - - Google Patents

Download PDF

Info

Publication number
JP2018537408A5
JP2018537408A5 JP2018516713A JP2018516713A JP2018537408A5 JP 2018537408 A5 JP2018537408 A5 JP 2018537408A5 JP 2018516713 A JP2018516713 A JP 2018516713A JP 2018516713 A JP2018516713 A JP 2018516713A JP 2018537408 A5 JP2018537408 A5 JP 2018537408A5
Authority
JP
Japan
Prior art keywords
oxy
amine
amino
methyl
dimethylpentyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018516713A
Other languages
English (en)
Japanese (ja)
Other versions
JP6785302B2 (ja
JP2018537408A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/054471 external-priority patent/WO2017059085A1/en
Publication of JP2018537408A publication Critical patent/JP2018537408A/ja
Publication of JP2018537408A5 publication Critical patent/JP2018537408A5/ja
Application granted granted Critical
Publication of JP6785302B2 publication Critical patent/JP6785302B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018516713A 2015-10-01 2016-09-29 ビアリールキナーゼ阻害剤 Active JP6785302B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3170/DEL/2015 2015-10-01
IN3170DE2015 2015-10-01
PCT/US2016/054471 WO2017059085A1 (en) 2015-10-01 2016-09-29 Biaryl kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2018537408A JP2018537408A (ja) 2018-12-20
JP2018537408A5 true JP2018537408A5 (enExample) 2019-11-07
JP6785302B2 JP6785302B2 (ja) 2020-11-18

Family

ID=57190217

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018516713A Active JP6785302B2 (ja) 2015-10-01 2016-09-29 ビアリールキナーゼ阻害剤

Country Status (7)

Country Link
US (1) US10544120B2 (enExample)
EP (1) EP3356340B1 (enExample)
JP (1) JP6785302B2 (enExample)
KR (1) KR102704295B1 (enExample)
CN (2) CN112142655A (enExample)
ES (1) ES2765730T3 (enExample)
WO (1) WO2017059085A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20170004A1 (es) 2014-04-02 2017-03-04 Bristol Myers Squibb Co Inhibidores de biaril cinasa
KR102704295B1 (ko) 2015-10-01 2024-09-05 브리스톨-마이어스 스큅 컴퍼니 비아릴 키나제 억제제
WO2017059080A1 (en) 2015-10-01 2017-04-06 Bristol-Myers Squibb Company Biaryl kinase inhibitors
WO2018116139A1 (en) 2016-12-19 2018-06-28 Novartis Ag New picolinic acid derivatives and their use as intermediates
CN115484951A (zh) * 2020-04-21 2022-12-16 莱西肯医药有限公司 用于治疗病毒感染的aak1抑制剂
CN111995583A (zh) * 2020-08-18 2020-11-27 上海毕得医药科技有限公司 一种1,5-二甲基嘧啶-2(1h)-酮的合成方法
EP4371980A4 (en) 2021-07-15 2024-12-11 Xizang Haisco Pharmaceutical Co., Ltd. AAK1 INHIBITOR AND USE THEREOF
CN119095826A (zh) 2022-03-01 2024-12-06 莱西肯医药有限公司 用于合成aak1抑制剂的方法和化合物
AU2023229156A1 (en) 2022-03-01 2024-08-15 Lexicon Pharmaceuticals, Inc. Solid forms of (s)-l-((2',6-bis(difluoromethyl)-[2,4'-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine and salts thereof
TW202423433A (zh) * 2022-11-10 2024-06-16 大陸商西藏海思科製藥有限公司 含aak1抑制劑的藥物组合物
CN120641406A (zh) * 2023-01-16 2025-09-12 上海海雁医药科技有限公司 杂环取代的含氮杂环衍生物、其药物组合物及应用与制备方法
CN118772152B (zh) * 2023-04-07 2026-01-02 艾立康药业股份有限公司 作为aak1抑制剂的氮杂环类化合物
AU2024253688A1 (en) * 2023-04-07 2025-10-23 Alicorn Pharmaceutical Co., Ltd. Nitrogen-containing heterocyclic compound as aak1 inhibitor
WO2025092928A1 (zh) * 2023-11-02 2025-05-08 西藏海思科制药有限公司 一种可抑制连接蛋白相关激酶1的化合物、制备及其用途
KR20250158680A (ko) 2024-04-29 2025-11-06 심플렉스 주식회사 신규한 헤테로아릴 유도체 및 이의 aak1 억제 용도

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003286895A1 (en) * 2002-11-05 2004-06-07 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of jak and other protein kinases
AU2013226812B2 (en) * 2012-02-29 2016-10-27 Mitsui Chemicals Crop & Life Solutions, Inc. Pest control composition including novel iminopyridine derivative
US8703953B2 (en) * 2012-03-09 2014-04-22 Bristol-Myers Squibb Company Aryl ether-base kinase inhibitors
WO2013134336A2 (en) 2012-03-09 2013-09-12 Lexicon Pharmaceuticals, Inc. Inhibition of adaptor associated kinase 1 for the treatment of pain
US8901305B2 (en) * 2012-07-31 2014-12-02 Bristol-Myers Squibb Company Aryl lactam kinase inhibitors
EP2958924B1 (en) 2013-02-22 2016-12-28 Bristol-Myers Squibb Company 5h-chromeno[3,4-c]pyridines as inhibitors of adaptor associated kinase 1 (aak1)
CN105517993B (zh) 2013-07-08 2018-07-13 百时美施贵宝公司 芳基酰胺激酶抑制剂
CN105683196B (zh) 2013-09-11 2018-12-21 百时美施贵宝公司 基于芳基醚的激酶抑制剂
AU2014323072B2 (en) * 2013-09-19 2018-01-18 Basf Se N-acylimino heterocyclic compounds
JP6276865B2 (ja) 2014-01-29 2018-02-07 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company アリールラクタムキナーゼ阻害剤
WO2015116492A1 (en) 2014-01-31 2015-08-06 Bristol-Myers Squibb Company Quinoline-based kinase inhibitors
PE20170004A1 (es) * 2014-04-02 2017-03-04 Bristol Myers Squibb Co Inhibidores de biaril cinasa
WO2016053794A1 (en) 2014-09-30 2016-04-07 Bristol-Myers Squibb Company Quinazoline-based kinase inhibitors
WO2016164295A2 (en) 2015-04-10 2016-10-13 Bristol-Myers Squibb Company Fused pyridines as kinase inhibitors
WO2017059080A1 (en) 2015-10-01 2017-04-06 Bristol-Myers Squibb Company Biaryl kinase inhibitors
KR102704295B1 (ko) 2015-10-01 2024-09-05 브리스톨-마이어스 스큅 컴퍼니 비아릴 키나제 억제제

Similar Documents

Publication Publication Date Title
JP2018537408A5 (enExample)
JP2017511329A5 (enExample)
RU2018138050A (ru) Производные тиазолопиридина как агонисты gpr119
JP2018529731A5 (enExample)
NZ604004A (en) Pyridone and aza-pyridone compounds and methods of use
JP2016522232A5 (enExample)
HRP20160635T1 (hr) Inhibitori pirimidina pde10
JP2012525395A5 (enExample)
HRP20211957T1 (hr) Analozi 1,4-disupstituiranog piridazina i postupci za liječenje stanja povezanih s nedostatkom smn
JP2019534324A5 (enExample)
JP2019526550A5 (enExample)
US10376510B2 (en) 2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer
RU2015100942A (ru) Производное пиперидинилпиразолпиридина
JP2016523977A5 (enExample)
JP2016525076A5 (enExample)
JP2016537384A5 (enExample)
JP2013522354A5 (enExample)
SI3183247T1 (en) Aminopyrimidinyl compounds as inhibitors of JAK
JP2019514878A5 (enExample)
JP2016530274A5 (enExample)
JP2016529292A5 (enExample)
TW202024089A (zh) 三唑并-嘧啶化合物及其用途
EP4529956A3 (en) Dosage form compositions comprising an inhibitor of bruton s tyrosine kinase
RU2013136542A (ru) Конденсированные производные аминодигидротиазина
JP2019503337A5 (enExample)